Documente Academic
Documente Profesional
Documente Cultură
Prognostic Value of
Quantitative Collateral
Assessment at Perfusion CT
0 absent
1 ≤50%but>0%
>50% but
2
<100%
3 100%
Regional leptomeningeal
collateral score. (rLMC score)
• Aim
To develop a technique for quantitative assessment of
collateral perfusion at CT and to investigate its value in
the prediction of outcome in patients with AIS.
Material and Methods
Study Population
• Retrospective analysis
• Patients with AIS who underwent thrombolytic therapy with or
without mechanical thrombectomy from May 2009 to August 2017
• Selection criteria
(a) had a diagnosis of AIS confirmed with diffusion-weighted imaging or CT
(b) underwent perfusion CT within 8 hours after stroke onset
(c) had occlusion of the MCA-M1 segment with or without internal carotid
artery
(d) underwent follow-up CT angiography or time-of-flight MR angiography at
24 hours
(e) underwent unenhanced CT or susceptibility-weighted imaging at 24 hours
(f) had clinical follow-up with assessment of the modified Rankin scale (mRS)
score at 90 days
• Excluded patients who had poor image quality due to motion artifacts or
incomplete imaging studies.
Data Collection
• Demographic, clinical, and radiologic data
Age
Sex
Onset-to-needle time (ONT)
Blood pressure
Baseline National Institutes of Health Stroke Scale (NIHSS) score
Prior antiplatelet use
• Risk factors
Smoking history
Hypertension
Diabetes mellitus
Hyperlipidemia
History of stroke or transient ischemic attack
Atrial fibrillation
Data Collection
• Modified Rankin scale (mRS)
• Patients were dichotomized into groups with good (mRS score ≤2) or poor
(mRS score >2) outcome at 90 days.
Score Definition
0 No symptoms at all
1 No significant disability despite symptoms: able to carry out all usual duties
and activities Good
2 Slight disability: unable to carry out all previous activities but able to look outcome
after own affairs without assistance
3 Moderate disability: requiring some help, but able to walk without assistance
• Quantitative Assessment
Collateral Status: Quantitative
Assessment
Reconstructed CT - Temporally MIP - Each ROI was then Merged images were
(tMIP) maps copied to the obtained by
angiograms
- An 20-year corresponding CBF overlaying the CBF
experienced blinded map
map onto the tMIP
neurologist (M.L.) - Maximum CBF
value within each
map with an opacity
outlines the whole
ROI was of 20%.
visible vessels within
the Sylvian fissure on subsequently
each image section achieved The highest CBF value from all sections
(usually 2-3 sections). was recorded as cCBFmax.
Interobserver Concordance
• For the cCBFmax , 5-year experienced blinded neurologist
(M.L.) also delineated the ROIs.
Compare to assess interobserver concordance
Continuous variables
Median (interquartile
range)
Statistical Analysis
Continuous variables
Categorical variables
Number of patients
(Percentage)
Statistical Analysis
Categorical variables
the Mann-
Whitney U test was used
to compare differences
between two groups
Statistical Analysis
• No significant difference
in other baseline
characteristics,
hemorrhagic
transformation, or good
outcome (all P > .05).
Patient Characteristics and cCBFmax
80 [65–107]
47 [27–62] 75 [62–98]
61 [43–94]
46 [25–59]
•
Published online: Jan 08, 2019
• Retrospective analysis
( from May 2009 to Aug 2017 )
• Clinical outcome
Occurrence of hemorrhagic transformation ( at 24hr NECT or SWI )
Final infarct volume ( at 24hr NECT or DWI )
Recanalization ( at 24hr CTA or MRA)
Outcome at 90 days (mRS ≤ 2 or > 2)
• No dropout.
Step 1: Are the results of the study
valid?
• Were outcome criteria either objective or applied in a ‘blind’
fashion?
• Clinical outcome
Occurrence of hemorrhagic transformation - objective
Final infarct volume ( at 24hr NECT or DWI ) - objective
Recanalization ( at 24hr CTA or MRA) – using Arterial occlusive lesion scale ( grade
0-1 or grade 2-3)
Outcome at 90 days (mRS ≤ 2 or > 2) - objective
Step 2: What were the results?
• The cCBFmax:
• Better than modified Tan scale, Miteff scale, rLMC score but not baseline
NIHSS score or any pairs of assessment and baseline scale. (AUC values in
ROC analysis)
• Optimal cutoff cCBFmax = 64 mL/100 g/min.
Sensitivity = 79.2% (68.0 – 87.8)
Specificity = 62.9% (54.0 – 71.1)
Also an independent predictor of good outcome OR = 5.43 ( p < .001 )
Step 3: Will these results help me in
caring for my patients?
• Are the study results applicable to the patient in your practice?
ICC = 0.92